Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 17Breast 15Other 9Genitourinary 8Thoracic 7Gynecologic 4Other solid neoplasm 3Lymphoid 2Head & Neck 2Endocrine 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1NET 1CNS 1

Conditions

Sexual Dysfunction, Physiological 1Obesity 1Neuroendocrine Tumors 1Multiple Endocrine Neoplasia Type 1 1Inflammation 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nutrition Assessment × Endocrine × Clear all
NCT03143946 2024-05-06

DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor

University Medical Center Groningen

Phase NA Completed
53 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01554735 2015-07-29

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

Changi General Hospital

Phase 4 Completed
70 enrolled
EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡